Contributing Member of the Legal, Economic & Regulatory Affairs Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

An $80 Billion Giveback to the Government by Pharma can Result in a 2 times ROI !!!

July 14, 2009

Analysis of:The Pharmaceutical Industry Gives the Obama Health Care Initiative $80 Billion and Can Come Out with a Bigger Prize?? | pharmservices.blogspot.com

The Obama administration's push to drive health care costs down may not be all bad news for the Bio-pharmaceutical Industry. While the industry recently announced/agreed to an $80 billion reduction over 10 years ($8 billion/year) in cost reductions to Medicare, they may be able to recoup a large piece of that assuming the uninsured population become covered under a plan that encompasses prescription drug costs. Incremental pharmaceutical prescription revenues could jump by $6-50 billion/year based on the assumptions one uses in per capita spend on pharmaceuticals and number of people whom would actually be covered under the plan. Taking a very conservative midpoint of 20 million incremental increase in covered people and a midpoint spend of $750/year per consumer on pharmaceuticals yields an additional $15 billion per year in revenues which equates to $150 billion over the 10 year life of the program that the industry (generously?) proposed.

Full Disclosure of Pharmaceutical Companies Payments to Physicians to Become the Norm

September 25, 2008

Analysis of:Drug maker plans to disclose payments to doctors | news.yahoo.com

This is basically a "sleeves off the vest" move that is a defense against inevitable federal legislative requirements that will be coming in the near term. While the first mover advantage here is questionable, other pharmaceutical companies will have to follow.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS